ANI
25 Jan 2023, 16:48 GMT+10
By Shalini BhardwajNew Delhi [India], January 25 (ANI): A day after the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine for the prevention of cervical cancer, Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the availability of the vaccine will be little in number this year, however, it would be boosted next year.
Poonawalla briefed Union Health Minister Mansukh Mandaviya about the HPV vaccine in the national capital.
Speaking to ANI after the meeting, the SII CEO said, "I had come to brief the Union Health minister about it. We'll wait for the government program to roll out. Capacity is very small this year but we'll build a large capacity to take care of the entire nation's needs for next year."Talking about the rollout programme of the vaccine, Poonawalla said that it would be done through government programmes this year.
"We will slowly roll it out through government programs this year. I can't comment on pricing now. We will wait for tendering process and follow government protocols," he said.
On Tuesday Serum Institute of India launched first made-in-India HPV vaccine for cervical cancer.
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, announced the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer.
The launch took place in the presence of Home Minister Amit Shah, Adar Poonawalla, and the Director of GovernmentRegulatory Affairs at Serum Institute of India, Prakash K Singh.
"On the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, @SerumInstIndia is pleased to launch the first made-in-India HPV vaccine by the hands of our Hon'ble Home Minister Shri @AmitShah Ji. @PrakashKsingh7," tweeted Adar Poonawalla.
'CERVAVAC' is an outcome of a partnership of DBT and BIRAC with the Bill and Melinda Gates Foundation, supported by Serum Institute of India Private Limited for the indigenous development of quadrivalent vaccine through its partnership programme 'Grand Challenges India'. (ANI)Get a daily dose of China National News news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to China National News.
More InformationHANOI, Vietnam: During Chinese President Xi Jinping's visit to Hanoi this week, China and Vietnam agreed to take the first steps toward...
FORT WORTH, Texas: American Airlines will begin offering free high-speed Wi-Fi to passengers in January 2026, joining a growing list...
LONDON, UK: Electric vehicle sales surged globally in March, with strong growth in China and Europe offsetting slower momentum in North...
New York City: New York: Goldman Sachs has signaled a prolonged downturn in oil prices, forecasting a steady decline through the end...
NEW YORK, New York - U.S. stocks were volatile again Friday as President Donald Trump blasted Federal Reserve chair Jerome Powell for...
BRUSSELS, Belgium - The Europesn Central Bank has slashed official interest rates in the wake of the financial crisis triggered by...
HANOI, Vietnam: During Chinese President Xi Jinping's visit to Hanoi this week, China and Vietnam agreed to take the first steps toward...
The Australian Federal Police (AFP) are appealing to the public for assistance in locating Michael Connors, a 25-year-old Irish national...
ABOARD AIR FORCE ONE/TOKYO: U.S. President Donald Trump reaffirmed his opposition to a foreign takeover of U.S. Steel, casting renewed...
HONG KONG: Hong Kong's last major opposition party has begun the process of dissolving, a symbolic end to decades of pro-democracy...
TOKYO, Japan: As Japan prepares for critical trade talks with the United States, a top policymaker has stressed the need to strengthen...
BERLIN, Germany: Talks between the EU and China could pave the way for a shift from tariffs to minimum price agreements on Chinese...